Isatuximab Medication Information
Discover comprehensive details about Isatuximab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.
The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.
Additionally, explore the Isatuximab brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.
Generic Name : Isatuximab Pronunciation : I-suh-TUK-sih-mabBrand Names or Trade Names of Isatuximab
India :
Sarclisa
Overview of Isatuximab
Isatuximab is an anticancer agent indicated for the treatment of adults with multiple myeloma. Mutiple myeloma is a type of cancer that affects the plasma cells of the white blood cell.It should be used along with chemotherapy drug pomalidomide with steroid -dexamethasone among patients who have received at least two prior chemotherapies with lenalidomide and a proteasome inhibitor.
Why is Isatuximab Prescribed? (Indications)
Isatuximab is an anticancer agent indicated for the treatment of adults with multiple myeloma.When should Isatuximab not be taken? (Contraindications)
Patients allergic to IsatuximabWhat is the dosage of Isatuximab?
Isatuximab is available as an injection:10mg/kg body weight
20mg/kg body weight
How should Isatuximab be taken?
The recommended dosage is 10 mg/kg body weight, given as an intravenous infusion every week for 4 weeks followed by every 2 weeks along with pomalidomide and dexamethasone.It should be given for 28 days.
Missed a Dose?
If a planned dose of Istauximab is missed, administer the dose as soon as possible and adjust the treatment schedule accordingly, maintaining the treatment interval.What are the warnings and precautions for Isatuximab?
• Pregnant and lactating women should use this drug.• If a lactating woman uses the drug, breastfeeding should be avoided.
• Safety of usage was not established in children.
What are the side effects of Isatuximab?
•General: Infusion-related reactions, low white blood cell count•Digestive: Nausea, vomiting, diarrhea
•Respiratory: Pneumonia, upper respiratory tract infection, dyspnea, or difficulty in breathing
What are the other precautions for Isatuximab?
•Infusion-related reactions can occur. If a reaction occurs, the infusion must be discontinued.•In women who are in child bearing age, proper contraceptives should be used as it can cause fetal harm
•Monitor blood cell counts periodically during treatment, especially neutrophil (A kind of white blood cell)
•Monitor patients for the development of second primary malignancies (cancers).
